IBO
Impact BioMedical·AMEX
--
--(--)
--
--(--)
6.14 / 10
Outperform
Fundamental analysis of Impact BioMedical Inc reveals encouraging conditions with a fundamental score of 6.1/10. Key strengths include a healthy Interest coverage ratio (15.48%), robust revenue growth (Operating revenue YoY +92.66% and Total operating revenue YoY +78.47%), and favorable Revenue-MV and Profit-MV metrics. However, Days sales outstanding is elevated at 2149.2, indicating potential inefficiencies in receivable collection. Overall, the fundamentals are solid but not without areas needing improvement.
Analysis Checks(9/10)
Revenue-MV
Value-4.84
Score3/3
Weight17.04%
1M Return10.54%
Value-4.84
Score3/3
Weight17.04%
1M Return10.54%
Days sales outstanding
Value2149.20
Score1/3
Weight-1.87%
1M Return-1.57%
Value2149.20
Score1/3
Weight-1.87%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
PB-ROE
Value-0.59
Score3/3
Weight18.43%
1M Return12.83%
Value-0.59
Score3/3
Weight18.43%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Revenue-MV
Value-4.84
Score3/3
Weight17.04%
1M Return10.54%
Value-4.84
Score3/3
Weight17.04%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Days sales outstanding
Value2149.20
Score1/3
Weight-1.87%
1M Return-1.57%
Value2149.20
Score1/3
Weight-1.87%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
PB-ROE
Value-0.59
Score3/3
Weight18.43%
1M Return12.83%
Value-0.59
Score3/3
Weight18.43%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Is IBO undervalued or overvalued?
- IBO scores 6.14/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, 0.00% net margin, -1.12 P/E ratio, -5.57 P/B ratio, and -2070.00% earnings growth, these metrics solidify its Outperform investment rating.
